Monika Marcinkowska - Concepedia

Author

Monika Marcinkowska

Jagiellonian University ORCID

Also Known As

M. Marcinkowska, Monika M. MARCINKOWSKA, Monika MARCINKOWSKA, Monika Marcinkowska

Publications

987

Citations

H-Index

Concepts

All Affiliations

Jagiellonian University Adamed (Poland)Institute of Psychiatry and Neurology Medicina Pomeranian Medical University

About

Monika Marcinkowska is an author at Jagiellonian University specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	230
2	Social Sciences	2	2	47
3	Engineering	1	1	11
4	Natural Sciences	1	1	33
5	Biomolecular Engineering	1	1	29

Monika Marcinkowska

Publications

637

Citations

H-Index

Page 1

	Year	Citations
Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation Anna Więckowska, Marcin Kołaczkowski, Adam Bucki, European Journal of Medicinal Chemistry Molecular PharmacologyNeurodegenerative DiseasesDrug TargetAlzheimer's DiseaseNovel Multi-target-directed Ligands	2016	84
Novel Arylsulfonamide Derivatives with 5-HT<sub>6</sub>/5-HT<sub>7</sub>Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia Marcin Kołaczkowski, Monika Marcinkowska, Adam Bucki, Journal of Medicinal Chemistry	2014	66
Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease Anna Więckowska, Tomasz Wichur, Justyna Godyń, ACS Chemical Neuroscience	2018	52
The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H2S) Delivery Molecule AP39 Induces Brain Tolerance to Ischemia Bartosz Pomierny, Weronika Krzyżanowska, Jakub Jurczyk, International Journal of Molecular Sciences	2021	48
Idalopirdine – a small molecule antagonist of 5-HT6 with therapeutic potential against obesity Magdalena Dudek, Monika Marcinkowska, Adam Bucki, Metabolic Brain Disease	2015	41
Idalopirdine, a selective 5-HT6 receptor antagonist, reduces food intake and body weight in a model of excessive eating Magdalena Kotańska, Klaudia Lustyk, Adam Bucki, Metabolic Brain Disease	2018	39
Design, synthesis, and biological evaluation of fluorinated imidazo[1,2- a ]pyridine derivatives with potential antipsychotic activity Monika Marcinkowska, Marcin Kołaczkowski, Krzysztof Kamiński, European Journal of Medicinal Chemistry Medicinal ChemistryPotential Antipsychotic ActivityNatural SciencesMedicineFluorous Synthesis	2016	33
Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia Marcin Kołaczkowski, Monika Marcinkowska, Adam Bucki, European Journal of Medicinal Chemistry Alzheimer's DiseasePsychiatryPsychotropic MedicationDementiaBehavioral Pharmacology	2014	31
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1<i>H</i>-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity Adam Bucki, Monika Marcinkowska, Joanna Śniecikowska, Journal of Medicinal Chemistry Psychotropic MedicationHerg ChannelPsychopharmacologyOrganic ChemistryPharmacotherapy	2017	29
Varied effect of fortification of kale sprouts with novel organic selenium compounds on the synthesis of sulphur and phenolic compounds in relation to cytotoxic, antioxidant and anti-inflammatory activity Paweł Paśko, Agnieszka Galanty, Paweł Zagrodzki, Microchemical Journal	2022	25

Page 1